Physician profile
Ilyse Robin Nayor
NPI 1265545610
$980.00
in general payments reported to CMS, 2019-2025
17 companies · $270 in 2025
The $270 reported for 2025 was more than what 82% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $55.09 · 2020: $26.22 · 2021: $59.54 · 2022: $69.71 · 2023: $197 · 2024: $302 · 2025: $270.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $769.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $769.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $259.06 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $112.46 | 2022-2025 | Gardasil 9, Proquad, Vaxelis |
| Cranial Technologies, INC | $86.04 | 2020-2025 | Doc Band |
| Glaxosmithkline, LLC. | $70.31 | 2024-2025 | Bexsero |
| Verrica Pharmaceuticals INC. | $67.17 | 2024 | Ycanth |
| Seqirus USA INC | $60.86 | 2023-2024 | Flucelvax, Flucelvax Quadrivalent |
| Kaleo, INC. | $59.88 | 2021-2024 | Auvi-Q |
| Hologic Sales and Service, LLC | $46.35 | 2023 | Thinprep 2000 Processor, Aptima |
| Incyte Corporation | $37.41 | 2022-2025 | Opzelura |
| Cognoa, INC. | $35.85 | 2021 | |
| Alexion Pharmaceuticals, INC. | $35.63 | 2023-2025 | Strensiq, Koselugo |
| Ars Pharmaceuticals Operations, INC. | $29.21 | 2025 | Neffy |
| Alk-Abello, INC | $23.10 | 2025 | Neffy |
| Ironwood Pharmaceuticals, INC | $18.41 | 2024 | |
| Corium, LLC | $17.58 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dermira, INC. | $11.40 | 2020 | |
| Quidel Corporation | $9.28 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ilyse Nayor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.